文献速递儿童消化与营养儿童血液肿瘤与免疫

每日锌、微量营养素粉或治疗性锌补充对老挝农村儿童体格生长、贫血及微量营养素状况的影响:一项随机对照试验

Effects of Daily Zinc, Daily Multiple Micronutrient Powder, or Therapeutic Zinc Supplementation for Diarrhea Prevention on Physical Growth, Anemia, and Micronutrient Status in Rural Laotian Children: A Randomized Controlled Trial.
PubMed 文献 · J Pediatr · 2018-12-21

该随机对照试验纳入3407名6-23月龄老挝农村儿童,比较每日预防性锌片、高锌低铁微量营养素粉、腹泻治疗性锌补充与安慰剂对生长和血液营养状况的影响,随访约9个月。结果显示预防性锌和微量营养素粉虽降低锌缺乏,但未改善生长迟缓;微量营养素粉改善铁缺乏并趋势性减少基线贫血患儿的贫血。

要点

  • 预防性锌和微量营养素粉显著降低锌缺乏,但未减少生长迟缓。
  • 微量营养素粉降低铁缺乏44%-55%,对总体贫血无显著影响。
  • 基线贫血患儿使用微量营养素粉趋势性降低贫血11%-16%。

核心结论

  • 预防性锌和微量营养素粉改善锌状况但未影响生长。
  • 微量营养素粉改善铁状况并趋势性减少基线贫血患儿的贫血。

研究设计与样本

  • 随机对照试验纳入3407名6-23月龄老挝农村儿童,随访约9个月。
  • 儿童随机接受每日预防性锌片7 mg/d、高锌低铁微量营养素粉(锌10 mg/d、铁6 mg/d及13种其他微量营养素)、腹泻治疗性锌20 mg/d连用10天或每日安慰剂粉。
  • 采用意向性分析,使用线性和改良Poisson回归。

主要发现

  • 基线平均年龄14.2±5.1个月,生长迟缓患病率37.9%,贫血患病率55.6%。
  • 终点时预防性锌组锌缺乏50.7%、微量营养素粉组59.1%,显著低于治疗性锌组79.2%和对照组78.6%(P < .001)。
  • 各组生长迟缓率37.1%-41.3%,无显著差异(P = .37)。
  • 微量营养素粉组铁缺乏较其他组降低44%-55%(P < .001),总体贫血无显著影响(P = .14)。
  • 基线贫血患儿使用微量营养素粉趋势性降低贫血11%-16%(P = .06)。

临床怎么用

  • 在类似人群中,预防性锌或微量营养素粉不能作为改善生长的单一干预。
  • 微量营养素粉可改善铁状况,对基线贫血患儿可能有益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the optimal zinc supplementation strategy for improving growth and hematologic and micronutrient status in young Laotian children. STUDY DESIGN: In total, 3407 children aged 6-23 months were randomized to receive either daily preventive zinc tablets (7 mg/d), high-zinc, low-iron micronutrient powder (10 mg/d zinc, 6 mg/d iron, and 13 other micronutrients), therapeutic zinc supplementation for diarrhea (20 mg/d for 10 days per episode), or daily placebo powder; all were followed for ~9 months. Anthropometry, hemoglobin, zinc, and iron status were assessed at baseline and endline. Analyses were by intention-to-treat, using linear and modified Poisson regression. RESULTS: At baseline, mean (±SD) age was 14.2 ± 5.1 months and stunting and anemia prevalence were 37.9% and 55.6%, respectively. At endline, zinc deficiency in the preventive zinc (50.7%) and micronutrient powder (59.1%) groups were significantly lower than in the therapeutic zinc (79.2%) and control groups (78.6%; P < .001), with no impact on stunting (37.1%-41.3% across the groups, P = .37). The micronutrient powder reduced iron deficiency by 44%-55% compared with other groups (P < .001), with no overall impact on anemia (P = .14). Micronutrient powder tended to reduce anemia by 11%-16% among children who were anemic at baseline (P = .06). CONCLUSIONS: Despite improving zinc status, preventive zinc and micronutrient powder had no impact on growth. The micronutrient powder improved iron status and tended to reduce anemia among the subset of previously anemic children. TRIAL REGISTRATION: ClinicalTrials.govNCT02428647.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Barffour MA, Hinnouho GM, Kounnavong S, et al. Effects of Daily Zinc, Daily Multiple Micronutrient Powder, or Therapeutic Zinc Supplementation for Diarrhea Prevention on Physical Growth, Anemia, and Micronutrient Status in Rural Laotian Children: A Randomized Controlled Trial. J Pediatr. 2018. PMID: 30580974. doi:10.1016/j.jpeds.2018.11.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。